Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NASDAQ:CADL

Recent news which mentions NASDAQ:CADL

CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024
Tickers CADL
Tags Earnings Reports NASDAQ:CADL Market News
From InvestorPlace
Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Candel Therapeutics’ (NASDAQ: CADL) Lead Candidate CAN-2409 Combats Lung, Pancreatic And Prostate Cancers With Fast Track Designation For Three Cancers
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer
Tickers CADL
Tags NASDAQ:CADL
From News Direct
CADL Stock Earnings: Candel Therapeutics Reported Results for Q1 2024
Tickers CADL
Tags Earnings Reports NASDAQ:CADL Market News
From InvestorPlace
CADL Stock Earnings: Candel Therapeutics Misses EPS for Q4 2023
Tickers CADL
Tags Earnings Reports NASDAQ:CADL Market News
From InvestorPlace
Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Moving Fast: Candel’s (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Candel Therapeutics Sets Stage For Success With Cancer-Fighting Immunotherapies
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.